Debating Drug Prices In The Shadow Of Coronavirus: Access Vs Innovation. Can Both Sides Win?

How much do new drugs cost to make, why, and what returns does industry need to sustain innovation?

Read the full post on Forbes - Healthcare

Standish Fleming, Contributor